PDT Partners’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

PDT Partners’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-124,181	Closed	-$1.9M	–	1132
2022 Q2	$1.9M	Buy	124,181 +71,472	+136%	+$1.06M	0.17%	188
2022 Q1	$1.07M	Sell	52,709 -6,267	-11%	-$128K	0.09%	347
2021 Q4	$1.72M	Sell	58,976 -27,365	-32%	-$783K	0.13%	257
2021 Q3	$1.86M	Buy	86,341 +17,841	+26%	+$431K	0.13%	253
2021 Q2	$1.76M	Buy	68,500 +14,761	+27%	+$315K	0.12%	287
2021 Q1	$980K	Buy	53,739 +34,439	+178%	+$572K	0.07%	375
2020 Q4	$223K	Buy	+19,300	New	+$176K	0.02%	600
2018 Q1	–	Sell	-66,900	Closed	-$260K	–	622
2017 Q4	$260K	Sell	66,900 -15,900	-19%	-$68.1K	0.01%	492
2017 Q3	$260K	Buy	+82,800	New	+$311K	0.01%	481

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

PDT Partners's CDMO Position: Q3 2022 in Review

PDT Partners sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2022, closing a stake of 124,181 shares — an estimated $1.9M sold.

PDT Partners first reported a position in CDMO in Q3 2017 and held it in 9 quarters. The position peaked at $1.9M in Q2 2022. 184 funds tracked by Wall St. Rank hold CDMO as of Q3 2022.

PDT Partners reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
PDT Partners sold 124,181 Avid Bioservices, Inc. Common Stock shares in Q3 2022, an estimated $1.9M.
PDT Partners first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
PDT Partners's Avid Bioservices, Inc. Common Stock position peaked at $1.9M in Q2 2022.
184 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2022.

Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.